Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer revision version was updated from v3.5.2 to v3.5.3, indicating an interface/software release rather than a change to the underlying study details.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, a site version/UI change that does not modify study details.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor metadata update with no visible changes to the study details.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study's Conditions, and updated the page version from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check94 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content changes were observed.SummaryDifference0.1%

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.